tag :: nebulizersandvaporizers

bookmarks (hide)
display
all
bookmarks only
bookmarks per page
5
10
20
50
100
sort by
added at
title
RSS
BibTeX
XML

No matching posts.

⟨⟨
⟨
⟩
⟩⟩

publications (hide)1
display
all
publications only
publications per page
5
10
20
50
100
sort by
added at
title
author
publication date
entry type
help for advanced sorting...
RSS
BibTeX
RDF
more...

1Designed delays versus rigorous pragmatic trials: lower carat gold standards can produce relevant drug evaluations.
M. Maclure, B. Carleton, and S. Schneeweiss. Medical care, 45 (10 Supl 2): S44-9 (October 2007)6352<m:linebreak></m:linebreak>GR: AG19463/AG/NIA NIH HHS/United States; JID: 0230027; 0 (Cyclooxygenase 2 Inhibitors); ppublish;<m:linebreak></m:linebreak>CER.
2 years ago by @jepcastel
show all tags
BritishColumbia
Cost-BenefitAnalysis
Cyclooxygenase2Inhibitors
Cyclooxygenase2Inhibitors:administration&dosa
Cyclooxygenase2Inhibitors:economics
DecisionMaking
DrugCosts
DrugEvaluation
DrugEvaluation:economics
DrugEvaluation:ethics
DrugEvaluation:methods
Humans
Insurance
InterprofessionalRelations
NationalHealthPrograms
NationalHealthPrograms:economics
NationalHealthPrograms:organization&administr
NationalHealthPrograms:statistics&numericald
NebulizersandVaporizers
NebulizersandVaporizers:economics
Organizational
PharmaceuticalServices
PharmaceuticalServices:economics
PharmaceuticalServices:statistics&numericalda
PolicyMaking
RandomizedControlledTrialsasTopic:economics
RandomizedControlledTrialsasTopic:ethics
ResearchDesign
RCT
BritishColumbiaCost-BenefitAnalysisCyclooxygenase2InhibitorsCyclooxygenase2Inhibitors:administration&dosaCyclooxygenase2Inhibitors:economicsDecisionMakingDrugCostsDrugEvaluationDrugEvaluation:economicsDrugEvaluation:ethicsDrugEvaluation:methodsHumansInsuranceInterprofessionalRelationsNationalHealthProgramsNationalHealthPrograms:economicsNationalHealthPrograms:organization&administrNationalHealthPrograms:statistics&numericaldNebulizersandVaporizersNebulizersandVaporizers:economicsOrganizationalPharmaceuticalServicesPharmaceuticalServices:economicsPharmaceuticalServices:statistics&numericaldaPolicyMakingRandomizedControlledTrialsasTopic:economicsRandomizedControlledTrialsasTopic:ethicsResearchDesignRCT
(0)
copydeleteadd this publication to your clipboard

⟨⟨
⟨
1
⟩
⟩⟩

BibSonomy

bookmarks (hide)
display
all
bookmarks only
bookmarks per page
5
10
20
50
100
sort by
added at
title
RSS
BibTeX
XML

publications (hide)1
display
all
publications only
publications per page
5
10
20
50
100
sort by
added at
title
author
publication date
entry type
help for advanced sorting...
RSS
BibTeX
RDF
more...

1Designed delays versus rigorous pragmatic trials: lower carat gold standards can produce relevant drug evaluations.

browse

related tags

BibSonomy

bookmarks (hide) displayallbookmarks onlybookmarks per page5102050100 sort byadded attitle RSSBibTeXXML

publications (hide)1 displayallpublications onlypublications per page5102050100 sort byadded attitleauthorpublication dateentry typehelp for advanced sorting... RSSBibTeXRDFmore...

1Designed delays versus rigorous pragmatic trials: lower carat gold standards can produce relevant drug evaluations.

browse

related tags

bookmarks (hide)
display
all
bookmarks only
bookmarks per page
5
10
20
50
100
sort by
added at
title
RSS
BibTeX
XML

publications (hide)1
display
all
publications only
publications per page
5
10
20
50
100
sort by
added at
title
author
publication date
entry type
help for advanced sorting...
RSS
BibTeX
RDF
more...